Cargando…

Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report

PURPOSE: To report on a case of diffuse unilateral subacute neuroretinitis (DUSN) that was successfully treated with a short course of oral albendazole. OBSERVATIONS: A 51-year-old male presented with severe visual loss secondary to DUSN associated with a positive Toxocara serology. Because the para...

Descripción completa

Detalles Bibliográficos
Autores principales: Amaral, Claudia, Jimenez, Hiram, Davila, Pedro, Ulloa-Padilla, Jan P., Guiot, Humberto M., Oliver, Armando L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970060/
https://www.ncbi.nlm.nih.gov/pubmed/33748536
http://dx.doi.org/10.1016/j.ajoc.2021.101054
_version_ 1783666360408080384
author Amaral, Claudia
Jimenez, Hiram
Davila, Pedro
Ulloa-Padilla, Jan P.
Guiot, Humberto M.
Oliver, Armando L.
author_facet Amaral, Claudia
Jimenez, Hiram
Davila, Pedro
Ulloa-Padilla, Jan P.
Guiot, Humberto M.
Oliver, Armando L.
author_sort Amaral, Claudia
collection PubMed
description PURPOSE: To report on a case of diffuse unilateral subacute neuroretinitis (DUSN) that was successfully treated with a short course of oral albendazole. OBSERVATIONS: A 51-year-old male presented with severe visual loss secondary to DUSN associated with a positive Toxocara serology. Because the parasite could not be detected on fundoscopy, first-line treatment with photocoagulation could not be administered. Treatment with a 6-day course of oral albendazole resulted in the resolution of DUSN as well as the restoration of visual acuity. CONCLUSION AND IMPORTANCE: Although DUSN is characterized by the presence of a parasitic organism in the retina, there are cases in which the parasite is not visible. Albendazole has been used to treat such cases, but a standard treatment regimen has not been determined yet. Our case suggests that the resolution of DUSN can be achieved with short-term albendazole therapy.
format Online
Article
Text
id pubmed-7970060
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79700602021-03-19 Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report Amaral, Claudia Jimenez, Hiram Davila, Pedro Ulloa-Padilla, Jan P. Guiot, Humberto M. Oliver, Armando L. Am J Ophthalmol Case Rep Case Report PURPOSE: To report on a case of diffuse unilateral subacute neuroretinitis (DUSN) that was successfully treated with a short course of oral albendazole. OBSERVATIONS: A 51-year-old male presented with severe visual loss secondary to DUSN associated with a positive Toxocara serology. Because the parasite could not be detected on fundoscopy, first-line treatment with photocoagulation could not be administered. Treatment with a 6-day course of oral albendazole resulted in the resolution of DUSN as well as the restoration of visual acuity. CONCLUSION AND IMPORTANCE: Although DUSN is characterized by the presence of a parasitic organism in the retina, there are cases in which the parasite is not visible. Albendazole has been used to treat such cases, but a standard treatment regimen has not been determined yet. Our case suggests that the resolution of DUSN can be achieved with short-term albendazole therapy. Elsevier 2021-03-06 /pmc/articles/PMC7970060/ /pubmed/33748536 http://dx.doi.org/10.1016/j.ajoc.2021.101054 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Amaral, Claudia
Jimenez, Hiram
Davila, Pedro
Ulloa-Padilla, Jan P.
Guiot, Humberto M.
Oliver, Armando L.
Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report
title Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report
title_full Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report
title_fullStr Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report
title_full_unstemmed Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report
title_short Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report
title_sort short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970060/
https://www.ncbi.nlm.nih.gov/pubmed/33748536
http://dx.doi.org/10.1016/j.ajoc.2021.101054
work_keys_str_mv AT amaralclaudia shorttermoralalbendazoletherapyfordiffuseunilateralsubacuteneuroretinitisacasereport
AT jimenezhiram shorttermoralalbendazoletherapyfordiffuseunilateralsubacuteneuroretinitisacasereport
AT davilapedro shorttermoralalbendazoletherapyfordiffuseunilateralsubacuteneuroretinitisacasereport
AT ulloapadillajanp shorttermoralalbendazoletherapyfordiffuseunilateralsubacuteneuroretinitisacasereport
AT guiothumbertom shorttermoralalbendazoletherapyfordiffuseunilateralsubacuteneuroretinitisacasereport
AT oliverarmandol shorttermoralalbendazoletherapyfordiffuseunilateralsubacuteneuroretinitisacasereport